<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
NURESCELL INC.
(Name of Issuer)
COMMON STOCK, $.0001 par value
(Title of Class of Securities)
67057R 10 1
(CUSIP Number)
Adrian A. Joseph, Ph.D.; 1400 Bristol Street North
Suite 240, Newport Beach, California 92660 (949)752-0071
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
June 15, 2000
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement or Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1 (b)(3) or (4), check the following box / /.
Check the following box if a fee is being paid with the statement / /. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are
to be sent.
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 5 Pages
<PAGE>
CUSIP NO. 67057R 10 1 13D Page 2 of 5 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Adrian A. Joseph, Ph.D.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)/ /
(b)/ /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO/PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
-0-
-------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 2,990,750
OWNED BY
EACH -------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON
WITH -0-
-------------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,990,750
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,990,750
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/ /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
19.1%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 67057R 10 1 13D Page 3 of 5 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dianna Joseph
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)/ /
(b)/ /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO/PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
-0-
-------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 2,990,750
OWNED BY
EACH -------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON
WITH -0-
-------------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,990,750
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,990,750
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/ /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
19.1%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
This Amendment No. 3 amends the Statement on Schedule 13D filed with
the Securities and Exchange Commission on April 7, 1999, Amendment No. 1 thereto
filed with the Securities and Exchange Commission on December 3, 1999 and
Amendment No. 2 thereto filed with the Securities and Exchange Commission on
March 13, 2000 (collectively, the "Schedule 13D") by Adrian A. Joseph, Ph.D. and
Dianna Joseph, with respect to the shares of Common Stock, par value $0.0001 of
Nurescell Inc. Unless otherwise defined herein, all capitalized terms shall have
the meaning ascribed to them in the Schedule 13D.
Item 5 of the Schedule 13D is hereby amended in its entirety to read as follows:
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) The 2,990,750 shares beneficially owned by the Josephs (the
"Shares") constitute approximately 19.1% of Nurescell's Common Stock outstanding
as of January 13, 2001.
(b) The Josephs share the voting and dispositive power with respect to
the Shares.
(c) The Josephs have engaged in the following transactions with respect
to Nurescell's Common Stock since the most recent filing of Schedule 13D:
<TABLE>
Transaction Number of Price Per Type of
Date Shares Share Transaction
------------- --------- --------- -----------
<S> <C> <C> <C>
4/18/00 25,000 N/A Gift
4/27/00 2,000 N/A Gift
5/5/00 2,000 N/A Gift
6/10/00 117,000 $1.50 Sale
6/15/00 25,000 N/A Gift
7/26/00 36,000 $1.50 Sale
7/26/00 7,000 $1.43 Sale
7/27/00 15,000 $1.50 Sale
11/6/00 3,000 $0.25 Sale
11/6/00 28,000 $1.25 Sale
1/11/01 3,500,000 * Sale
</TABLE>
* Exchanged for 3,500,000 shares of common stock of Advanced Technology
Industries, Inc.
(d) Not applicable.
(e) Not applicable.
Page 4 of 5
<PAGE>
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATED: January 13, 2001
/s/ Adrian A. Joseph, Ph.D.
-------------------------------
Adrian A. Joseph, Ph.D.
/s/ Dianna Joseph
-------------------------------
Dianna Joseph
Page 5 of 5
